Gene expression within a cell population can be directly altered through gene delivery approaches. Traditionally for nonviral delivery, plasmids or siRNA molecules, encoding or targeting the gene of interest, are packaged within nanoparticles. These nanoparticles are then delivered to the media surrounding cells seeded onto tissue culture plastic; this technique is termed bolus delivery. Although bolus delivery is widely utilized to screen for efficient delivery vehicles and to study gene function in vitro, this delivery strategy may not result in efficient gene transfer for all cell types or may not identify those delivery vehicles that will be efficient in vivo. Furthermore, bolus delivery cannot be used in applications where patterning of gene expression is needed. In this chapter, we describe methods that incorporate material surfaces (i.e., surface-mediated delivery) or hydrogel scaffolds (i.e., hydrogel-mediated delivery) to efficiently deliver genes. This chapter includes protocols for surface-mediated DNA delivery focusing on the simplest and most effective methods, which include nonspecific immobilization of DNA complexes (both polymer and lipid vectors) onto serum-coated cell culture polystyrene and self-assembled monolayers of alkanethiols on gold. Also, protocols for the encapsulation of DNA/cationic polymer nanoparticles into hydrogel scaffolds are described, including methods for the encapsulation of low amounts of DNA (<0.2 μg/μL) and high amounts of DNA (>0.2 μg/μL) since incorporation of high amounts of DNA poses significant challenges due to aggregation.
Introduction
Gene expression within a cell population can be directly altered through gene delivery approaches, which have tremendous potential for therapeutic applications, such as gene therapy to correct genetic deficiencies or tissue engineering scaffolds, where gene delivery can present chemical factors to guide tissue formation in regeneration matrices for treatment of organ loss and failure. Furthermore, gene delivery is often critical to research applications, such as functional genomics, cell culture studies, and biotechnological assays. Gene delivery can be performed with both viral and nonviral vectors, the latter of which are the focus of the techniques described in this chapter. Traditionally for nonviral delivery, plasmids or siRNA molecules, encoding or targeting the gene of interest, are packaged within nanoparticles. These nanoparticles are then delivered to the media surrounding cells seeded onto tissue culture plastic; this technique is termed bolus delivery ( Figure 1 ). Although bolus delivery is widely utilized to screen for efficient delivery vehicles and to study gene function in vitro, this delivery strategy may not result in efficient gene transfer for all cell types or may not identify those delivery vehicles that will be efficient in vivo. Furthermore, bolus delivery cannot be used in applications where patterning of gene expression is needed. In this chapter, we describe methods that incorporate material surfaces (i.e., surface-mediated delivery) or hydrogel scaffolds (i.e., hydrogel-mediated delivery) to efficiently deliver genes ( Figure 1 ).
Surface-mediated delivery, also termed solid-phase delivery or reverse transfection, refers to the delivery of nucleic acid nanoparticles from a surface or biomaterial that supports cell adhesion. DNA nanoparticles are immobilized to the surface or biomaterial and cells are plated directly on top of the immobilized nanoparticles (Figure 1 ), which enhances the extent of transgene expression, along with increasing cell viability (1) . This method of delivery was first described in 2002 using a specific avidin-biotin bond to tether nanoparticles to surfaces (2, 3) and was later extended to nonspecific absorption of the nanoparticles to a variety of biomaterial surfaces (1, (4) (5) (6) (7) (8) (9) (10) . Nonspecific adsorption of nanoparticles is accomplished through noncovalent mechanisms (1, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , including hydrophobic, electrostatic, and van der Waals interactions. Nonspecific binding depends upon the molecular composition of the vector (e.g., lipid versus polymer) and the relative quantity of each (e.g., nitrogen-to-phosphate ratio or N/P), as well as properties of the surface (e.g., hydrophilicity, charge, presence of serum proteins).
In surface-mediated delivery, DNA is concentrated at the delivery site and targeted to cells adhered to the substrate (1-3, 15) . The major advantages of surface-mediated DNA delivery are the following: (1) decreased nucleic acid nanoparticle aggregation and degradation, since nanoparticles can be produced in the most favorable buffer for their formation and then immobilized to the surface, which preserves the size observed in solution and avoids exposure of the particles in solution to the cell culture media, which often induces aggregation and decomplexation; (2) cells cultured on the substrate are exposed to elevated DNA concentrations within the local microenvironment (but typically overall concentration of DNA is minimized when compared to bolus techniques), which enhances transfection and minimizes cytotoxicity (1-10, 16) ; (3) elimination of mass transport limitations for the nanoparticles to reach the cell; and (4) immobilization of DNA complexes to substrates allows for the ability to pattern transfection (9, 17) , allowing for spatial control of gene delivery, which is critical for biotechnological and tissue engineering applications. Below, the reader will find protocols for surface-mediated DNA delivery focusing on the simplest and most effective methods, which include nonspecific immobilization of DNA complexes (both polymer and lipid vectors) onto serum-coated cell culture polystyrene and self-assembled monolayers (SAMs) of alkanethiols on gold.
Hydrogel-mediated delivery has been studied for over a decade primarily through the encapsulation of naked DNA during hydrogel formation. Naked DNA has been successfully incorporated inside hydrogels composed of collagen (18) , pluronic-hyaluronic acid (19) , dimethacrylated poly(lactic acid)-bpoly(ethylene glycol)-b-poly(lactic acid) triblock copolymers (20) , alginate (21) , oligo(polyethylene glycol) fumarate (22) , and engineered silk elastin (23) . Although naked DNA has shown gene expression and ability to guide regeneration in vivo (18, 24) , limitations with low gene transfer efficiency and rapid diffusion of the DNA from the hydrogel scaffold motivated the use of DNA nanoparticles instead of naked DNA. DNA condensed either with cationic peptides, lipids, or polymers has been introduced into fibrin hydrogels (25) (26) (27) (28) (29) , enzymatically degradable PEG hydrogels (30) , and PEG-hyaluronic acid hydrogels (26) . The delivery of genes from hydrogel scaffolds is becoming an attractive route to introduce foreign genes to cells for several reasons. First, in the biotechnology area, where new delivery agents are being investigated for in vivo gene transfer, the delivery of genes inside a matrix may be a better model for in vivo gene transfer. For example, hydrogels can be used to recreate disease models in vitro, including multiple cell types and complex extracellular matrices (e.g., cancer and organoid models). Second, in tissue engineering and regenerative medicine applications, it is often desired to transfect cells either infiltrating the scaffold (endogenous) or that are transplanted. In the case of endogenous cell transfection, the hydrogel scaffold serves as a depot that contains genes or siRNA that can transfect cells as the cells infiltrate the scaffold or the matrix is degraded and the genes or siRNA are released. In the case of transplanted cell transfection, the matrix and cells are encapsulated together. The goal here is to transfect the transplanted cells at a later time to induce their differentiation or the differentiation of nearby cells. Below, the reader will find protocols for the encapsulation of DNA/cationic polymer nanoparticles into hydrogel scaffolds. We divide the encapsulation into low amounts of DNA (<0.2 μg/μL) and high amounts of DNA (>0.2 μg/μL) since incorporation of high amounts of DNA poses significant challenges due to aggregation.
Materials
For surface-mediated delivery, the following reagents are necessary. , with the requirement that it is "tissue culture" polystyrene (indicating that it has been surface modified, typically through corona discharge or gas-plasma, to promote protein and cell adhesion (31, 32) ). These reagents are needed for the preparation of SAMs:
2.6. Ethanol: 200 Proof, filtered through a 0.22 μm filter, degassed with N 2 gas for at least 15 min.
2.7. Argon Gas: It is recommended to store the alkanethiol solutions and gold substrates under argon gas. Do not store SAMs under argon as it can cause toxicity issues.
2.8. 11-Mercaptoundecanoic Acid (MUA): 2 mM solution in ethanol, described above.
2.9. Gold Substrates: Gold-coated glass slides, composed of a titanium adhesion layer and 100-500 Å of gold, can be purchased commercially or prepared using e-beam evaporation. Gold-coated slides should be cut into smaller pieces with a diamond-tipped glass cutter so that pieces fit into standard 48-well tissue culture plates (for this protocol, may be adjusted based on experimental setup).
The following reagents are used for DNA nanoparticle preparation:
2.10. Reporter Plasmid DNA: Transfection is typically assessed by either fluorescent reporter genes (e.g., GFP or DS-red) or luminescent reporter genes (e.g., Firefly or Renilla Luciferase), or both. Plasmids are available commercially with these reporter genes, typically driven by CMV promoters. These plasmids can be expanded using commercially available prep kits such as the endotoxin free Giga Prep kit from Qiagen (see Note 3) and their expression assayed using fluorescent microscopy or commercially available kits. DNA is typically stored in TE buffer (10 mM Tris-Cl, pH 7.4-8.0, 1 mM EDTA, pH 8.0) at −20°C. Prepare stock solution in TE of 1 μg/ μL for complexation protocol below.
2.11. Branched Poly(Ethylene Imine) (PEI) Stocks:
1. Prepare 10 mg/mL solution of PEI (Sigma, branched, 25 kDa) in 0.1 M NaHCO 3 (sodium bicarbonate) (pH 8.2). Branched PEI is a liquid.
2. Using 6,000-8,000 MWCO tubing, dialyze the PEI against MilliQ water for 24 h, changing water at least three times over the course of dialysis.
3. After dialysis, lyophilize the PEI solution.
4. When lyophilization is complete, weigh the lyophilized PEI and resuspend in TBS buffer at 1 mg/mL. Store stocks at −20°C.
2.12. Linear PEI Stocks: Linear PEI (Polysciences, 25 kDa) comes as a very basic polymer with Cl -as a counterion. To remove excess Cl -ions, which would be present at neutral pH, the PEI is precipitated and dialyzed.
1. Dissolve 100 mg of PEI in 10 mL of DI water at room temperature. While stirring the solution bring the pH down to 7.4 using 1 N HCl to help dissolve it.
2. Precipitate the PEI by raising the pH to 12 with 1 N NaOH. Keep stirring the solution. The solution will turn white and blurry, but still stay in suspension. The PEI will be neutral since it will be deprotonated and it will become hydrophobic and insoluble in water.
3. Using 6,000-8,000 MWCO tubing, dialyze the precipitated PEI against DI water, pH 12 for 1 day to remove the chlorine ion (change water 2× every 2-3 h using 3-4 L DI water, pH 12 each time) and for 2-3 days against DI water (pH 7) to re-protonate. 4 . The PEI will become partially soluble in water again. After dialysis lyophilize the PEI solution.
5. Redissolve the entire 100 mg in 10 mL water or, alternatively, weigh out the desired amount of powder and dissolve it in water for a 10 mg/mL solution. About 10 μL of HCl per 3 mg of PEI will be required to help it dissolve. After the PEI is dissolved adjust the pH to 7.4.
6. Aliquot 1 mg/tube and lyophilize the PEI solution a second time. Store the lyophilized stocks at −20°C and resuspend in water or the desired buffer/saline solution. A typical final concentration is 1 μg/μL. Adjust final pH to 7.4.
Lipofectamine™ 2000 (Invitrogen™ by Life Technologies) is used (see Note 4).
Materials for hydrogel-mediated delivery are the following:
2.14. Triethanol amine (TEOA) Buffer: 0.3 M TEOA (stored under argon). Pipette 19.2 mL of ultrapure water into a beaker, add 0.8 mL of TEOA, and mix. Set pH to 8.6-8.7 with 37% HCl (the initial pH is 9-10 and requires 20-40 droplets). Sterile filter the final buffer. Use immediately or alternatively the buffer can be placed into aliquots and stored at −20°C under argon until use.
PEG-VS:
1. Dissolve four-arm PEG-OH in tetrahydrofuran (THF) under inert atmosphere and heat to reflux in a Soxhlet apparatus filled with molecular sieves for 3-4 h.
2. Allow the solution to cool to the touch and add sodium hydride (NaH; please note that NaH is a highly flammable material when in contact with water), at fivefold molar excess over OH groups, followed by the addition of divinyl sulfone, at 50-fold molar excess over OH groups.
3. Allow the reaction to continue at room temperature (RT) under argon atmosphere with constant stirring for 3 days.
4. Neutralize the reaction solution with acetic acid, filter it, concentrate by roto-evaporation, and precipitate it in ice-cold diethyl ether.
5. Precipitation should be repeated three times to remove unreacted divinyl sulfone.
6. Dry the final product under vacuum and store under argon at −20°C. 4. Maintain the pH at 4.75 until it becomes stable (~2 h) and let it react overnight.
5. Purify HA-ADH through dialysis (6,000-8,000 MWCO) against DI water for 3 days, changing the water at least 2× per day.
6. Collect the purified HA-ADH and lyophilize it until completely dry (~2 days). Dry HA-ADH can be stored at −20°C until the next step.
Using these reaction conditions, ~40% of the carboxyl groups are modified with ADH based on the trinitrobenzene sulfonic acid (TNBSA, Pierce) assay.
7. Make reaction buffer: 10 mM HEPES with 150 mM NaCl and 10 mM EDTA at pH 7.2.
8. Dissolve HA-ADH in reaction buffer for a final concentration of ~5.5 mg/mL. Mix using a stir bar and plate for about 2 h to completely dissolve.
9. Weigh out 1 g N-acryloxysuccinimide (NHS-Ac, ~3-4 molar excess over amine groups) and dissolve in 10 mL DMSO. Keep on ice.
10. React HA-ADH with NHS-Ac by adding 1 mL NHS-Ac in DMSO every 15-20 min and let it react overnight.
11. Purify HA-AC through dialysis (6,000-8,000 MWCO) against DI water for 3 days, changing the water at least 2× per day.
12. Collect the purified HA-Ac and lyophilize it until completely dry (~2 days). Dry HA-Ac can be stored at −20°C until used.
The degree of functionalization should be confirmed with 1H NMR (in D2O).
2.17. Peptide Crosslinker Aliquots: Michael addition chemistry can be used to cross-link PEG-VS or HA-AC into a hydrogel. Any di-thiol-containing molecule would work; however, to make the hydrogel degradable by cells protease degradable peptides are generally used. The peptide Ac-GCRDG-PQGIWGQDRCG-NH 2 (synthesized through solid-phase peptide synthesis or commercially purchased) has been used by several groups (for reviews see Refs. 33, 34) . Aliquots of the peptide are made to prevent its exposure to oxygen and disulfide bond formation. The peptide crosslinker powder is dissolved in 0.1% TFA, aliquoted into microcentrifuge tubes, and lyophilized. Because TFA is a volatile salt the resulting lyophilized powder contains only the peptide. The amount to be aliquoted depends on the number of cross-links desired or r ratio, which is the molar ratio of -SH groups to -VS or -AC groups. For example, for 100% modified PEG-VS hydrogels with 6% PEG an r ratio close to 1 is used, while for a 40% modified HA-AC with 3% gel an r ratio close to 0.3 is used. Typically enough material is aliquoted to be used in a single use. No freeze-thaw cycles are recommended.
RGD Peptide Aliquots: Michael addition is used to modify PEG-VS or
HA-AC with cell adhesion peptides such as RGD. Similar to the peptide crosslinker aliquots, RGD peptide aliquots are made to prevent disulfide bond formation. RGD peptide powder (Ac-GCGYGRGDSPG-NH 2, synthesized through solid-phase peptide synthesis or commercially purchased) is dissolved in 0.1% TFA, aliquoted into microcentrifuge tubes, and lyophilized. The amount to be aliquoted depends on the amount of RGD desired inside the hydrogel material (typically 30-500 μM final concentration for HA hydrogels and 30-200 μM for PEG-VS gels). Typically enough material is aliquoted to be used in a single use. No freeze-thaw cycles are recommended.
2.19. Reporter Plasmid DNA: To assess transfection from cells seeded inside hydrogel scaffolds, secreted proteins are recommended. The two most commonly used are secreted alkaline phosphatase mammalian expression vector (pSEAP, Genlantis, San Diego, CA) and Gaussia luciferase (pGLUC, New England Biolabs, Ipswich, MA). Both plasmids can be expanded using commercially available prep kits such as the endotoxin free Giga Prep kit from Qiagen and their expression assayed using commercially available kits.
2.20. Sigmacote-Coated Slides:
1. Prepare Sigmacote ® -coated glass slides by immersion of slides in Sigmacote ® solution using a 50 mL conical tube for 1 min and air drying for 3 min. Repeat this 3× for each slide (see Note 5).
2. After the third coating, place slides into oven above 100°C for 2 h to overnight to allow for complete drying.
3. Wash the slides with ethanol to sterilize before use. You should notice that the water slides off the slide easily.
2.21. Agarose: Dissolve 670 mg low-melting-point agarose in 1 L MQ H 2 O, allow 1-2 h to mix using a stir bar and stir plate, and filter solution using a 0.22 μm filter. Store stock solution at RT.
2.22. Sucrose: Dissolve 3.5 g sucrose in 10 mL Millipore water and filter solution using a 0.22 μm filter. Store stock solution at 4°C.
Methods

Surface-Mediated DNA Delivery
For substrate-mediated gene delivery, the properties of the surface are critical to both immobilization strategies and transfection efficiencies, as are the properties of the DNA complexes. Surface-mediated delivery has been reported on a variety of surfaces, including SAMs (9, 10), and standard tissue culture polystyrene (PS) plastic (1, (4) (5) (6) 35) . As the highest transfection levels were reported on carboxylic acid-terminated SAMs (9) and serum-coated PS (1), methods for these two surfaces are reported in this chapter. Methods are included for both polymer-and lipid-DNA complexes (Figure 2 ).
For Surface Preparation of Serum-Coated Polystyrene Proceed as Follows (See Also Notes 6-8)
1. Add 100 μL of 10% FBS per cm 2 (e.g., add 100 μL per well of a 48-well plate).
Let plate incubate at room temperature for 2 h (see Note 9).
3. After incubation, remove 10% FBS solution from wells and wash with 1× PBS (see Note 10).
For Surface Preparation of COO --Terminated SAMs Proceed as Follows (See Note 11)
1. Prepare 2 mM solution of MUA in filtered, degassed ethanol (see Note 12).
2. Wash gold substrates with copious amounts of acetone followed by ethanol. Dry gold substrates under a stream of N 2 gas.
3. Place gold surfaces into 2 mM MUA solution and allow monolayer formation to proceed for 45 min (see Note 13).
4. After monolayer formation, rinse SAMs with ethanol and dry surfaces under stream of N 2 gas.
5. Allow surfaces to equilibrate in PBS for 15 min to ensure deprotonation of terminal functional groups at physiological pH. 
After Complex Immobilization to Surfaces, Cells Are Seeded onto the Complexes and the Transfection Efficiency Analyzed
1. Seed 300 μL of cells in each well (15,000 cells/well) (see Note 24). 2. Incubate cells at 37°C and 5% CO 2 for 24-48 h. 3. Assay for transfection using fluorescence microscopy or luminescence assay (depending on the reporter gene present on plasmid) after 24-48 h (see Notes 25-27).
Hydrogel-Mediated Gene Delivery: Direct Encapsulation (<0.2 m g DNA/ m L Hydrogel)
The encapsulation of DNA into hydrogel scaffolds will require different protocols depending on the quantity of DNA loaded. Low amounts of DNA, <0.2 μg/μL, may be loaded into hydrogel scaffolds without significant aggregation. The following protocol is for the synthesis of a 100 μL 3% HA or 100 μL 6% PEG hydrogel scaffold with 0.05 μg DNA/ μL of hydrogel. We will be incorporating DNA complexed with linear PEI at an N/P ratio of 7 (see Note 28).
7. Place the gel(s) into the desired tissue culture plate size. The large gel can be cut with a biopsy punch to result in several small gels. 96-or 48-well plates are recommended for culturing to avoid diluting out the reporter protein.
8. By collecting the media of the cells and performing the appropriate assay, Phospha-light SEAP reporter gene assay system or Biolux gaussia luciferase assay kit, transfection can be monitored. Gene transfer has been observed as early as 2 days and as late as 7 days depending on the cell type and how well the cells migrate through the material. 5. Dissolve the crosslinker in 17 μL or 22 μL of ice-cold TEOA buffer and quickly add to the HA-RGD/Cell/polyplex suspension or the PEG-RGD/Cell/polyplex suspension. Mix thoroughly using a positive displacement pipette or a wide orifice tip (see Note 30) . The final gel solution should have a pH of 8.0-8.1. 6. Quickly cast the desired gels either as one large 100 μL gel or several small gels into the gel caster (Figure 4 ). Place gel caster at 37°C for 30 min. 
Notes
1. Invitrogen recommends the use of Opti-MEM ® I Reduced Serum Media for transfection with Lipofectamine 2000 (37). We have found that its use does enhance transfection, but for many cell lines other serum-free media can be used for formation of the lipoplexes.
2. Most of our protocols have been optimized with and utilize 48-well plate format. The least effective well for surface-mediated delivery is the 96-well plate, as those wells are often not perfectly flat and thus complexes deposit irregularly.
3. Any protocol for DNA preparation from bacterial cultures is sufficient, but "endotoxin-free" buffers are essential for transfection-grade DNA.
4. This chapter includes protocols for one lipid-based transfection reagent (Lipofectamine 2000) and one polymer-based transfection reagent (PEI). However, surface-mediated delivery has also been accomplished with jet-PEI (3, 16), Lipofectamine LTX (35) , FugeneHD (Rocher) (unpublished results), and Effectene (Qiagen) (35) , as well as viral vectors (15, (38) (39) (40) (41) (42) (43) . The encapsulation of lipoplexes and jetPEI/DNA polyplexes into hydrogel scaffolds has also been possible using a similar protocol (36).
5. After use, pour the Sigmacote ® back into a dark glass bottle (not back into the clean stock solution). This Sigmacote can be reused 3-4×.
6. Methods are per cm 2 , and can be scaled accordingly for different surface areas.
7. These methods can be modified to other surfaces including poly(lactide-co-glycolide) (PLGA) (7, 8, 11, 42) and collagen (11, 43) .
8. This protocol can also be modified to use purified extracellular matrix/serum proteins, including fibronectin, collagen, and laminin (5, 7), with fibronectin typically resulting in the highest transfection levels.
9. Serum incubation can proceed for longer periods of time, even overnight at 4°C, without negatively affecting transfection levels.
10. Perform this step right before adding complexes, as described under "Subheading 3.1.6."
11. Incorporation of poly(ethylene glycol) groups into carboxylic acid-terminated SAMs may increase transfection (10) 13. Typically we use gold substrates of ~0.5 cm 2 cut from a gold-coated microscope slide, as described above. These small pieces of gold are best handled with threeprong forceps. We typically form SAMs in foil-lined glass scintillation vials that contain 7-8 mL of MUA solution.
14. Both DNA amount and N/P ratio (or DNA:lipid ratio) need to be optimized for each cell type; the conditions used in this chapter represent good starting optimization points for NIH/3T3s; also these amounts are for a single well, so scale accordingly for multiple wells. For Lipofectamine™ 2000, Invitrogen recommends a Lipofectamine™/DNA ratio (μL/μg) between 0.5 and 5 for optimum transfection (37). For branched PEI, N/Ps are recommended between 10 and 25.
15. Adsorption is typically 10-20% of total DNA added to surfaces (1, 9) ; thus use approximately 5-10 times as much DNA as would typically be used in bolus conditions.
16. Can also use 150 mM NaCl to form polyplexes.
17. 60% of total complex volume should be with DNA.
18. 40% of total complex volume should be with PEI.
19. This order of addition is critical to transfection success.
20. During this time prepare surfaces for complex immobilization; for FBS-coated PS, remove the FBS and rinse with PBS as described above or for SAMs, incubate with PBS to ensure deprotonation.
21. We have found that even for lipids this order of addition is critical to transfection success.
22. Longer adsorption times result in larger mass of DNA complexes immobilized, but can also be associated with loss of activity; thus adsorption time is another variable that can be manipulated. 23 . Be sure that cell suspension is prepared and cells are ready to seed immediately after this rinsing step.
24. Cell density is for NIH/3T3s; this value will need to be optimized for each cell type.
25. Time after delivery to assay transfection may also need to be optimized.
26. For transfection studies on SAMs, move each SAM to a new well before proceeding with luminescence or protein assay to ensure that transfection is only measured in cells adhered to SAM and not on surrounding PS.
27. For transfection studies on SAMs, gold quenching of fluorescence may limit observation of transfection by fluorescent reporter genes. To reduce quenching, be sure to use upright microscope or fix cells and then place SAMs face down into well before imaging.
28. Encapsulation of polyplexes into fibrin, collagen, and UV cross-linked hydrogel scaffolds is also possible using the same protocols (36).
29. This 5 μL or 25 μL volume could be used to introduce other factors to the hydrogel such as growth factors. Further, this volume could be added to the cell volume to make the cell stock less concentrated.
30. The cell concentration in the gel and the cell concentration used in the stock solution should be optimized per cell type. For example, we have found that for MSCs 25,000 cells/μL is the highest concentration that can be used before severe cell death is observed post encapsulation. It is recommended to make different cell stock concentrations and make hydrogels without DNA/siRNA nanoparticles to determine the ideal cell concentration.
31. The amount of crosslinker added should be ~0.3 moles of thiol/mole of acrylate for the HA-AC hydrogel and 0.9 thiol/mole of vinyl sulfone for the PEG hydrogel. This is assuming a 40% modified HA molecule and a 100% modified PEG-VS polymer. This ratio can be varied to make hydrogels with different mechanical properties. It is recommended to use a spreadsheet program such as Microsoft Excel to calculate the ratio of thiols to acrylate or vinyl sulfone. Further the amount of crosslinker added will also be dependent on the activity of the crosslinker. Since the crosslinkers are bi-thiol molecules they are easily oxidized into disulfides. To determine the activity of the crosslinker, a thiol quantification assay such as the Ellman's assay should be performed. The moles of the crosslinker used to achieve a desired thiol/acrylate or vinyl sulfone ratio should be adjusted accordingly.
